SUNHO (CHINA) BIOPHARMACEUTICAL CO.,LTD

SUNHO (China) BioPharmaceutical Co., Ltd. (hereinafter referred to as SunHo) is located in Nanjing Economic and Technological Development Zone, Jiangsu Province, China. SunHo is a clinical-stage biopharmaceutical company dedicated to the discovery, development, manufacturing and commercialization of world-class innovative biotherapeutics and focuses on the field of cancer immunotherapy, autoimmune diseases and neurodegenerative diseases.

With multiple proprietary and patented platforms, such as Armed ImmunoCytokine Platform (AIC?) , Armed Innate-effector Multispecific Platform (AIM?) , ADCC Enhanced Antibody Platform (AEA?), SunHo has developed more than 20 globally innovative and differentiated R&D pipelines in oncology/immunology with 4 in clinical stage, 4 in IND application, 6 in preclinical, and many innovative projects in the early R&D stage. We are striving to develop the next generation and best-in-class medicines to address unmet medical needs with accessibility globally.......